Members of the ACCC IO Institute Executive Committee discuss why care coordination and communication among the IO team, other providers, and the patient is critical for effective delivery of immunotherapy for cancer. (features Mark Faries, MD; Sanjiv Agarwala, MD; and Niesha Griffith, MS, RPh, FASHP)
We sit down with journalist Mary Elizabeth Williams, one of the first patients treated with combination immunotherapy, to discuss her experience as an IO patient and how to bridge communication gaps among patients, doctors, and researchers.
Learn why a trip to the emergency department is different for patients who receive immunotherapy for cancer, what information helps ED clinicians, and what busy emergency department providers need to know about immune-related adverse events.
Immuno-oncology (IO) has radically altered the patient care paradigm. One of most important changes attributed to IO is improvement in outcomes and lengthening of survival. This good news comes with multiple challenges, not least of which is the need for new and better communication and coordination among multiple specialties over time.
Download Article & Companion Guide